Sarah Pringle

Company produces Ebitda of about $110 mln Sale could command multiple in high teens to 20x Advisers: Jefferies, Centerview Partners Vesey Street Capital is evaluating the sale of HealthChannels nearly five years into its investment in what is now the nation’s largest medical scribe company, five sources familiar with the situation told Buyouts. Jefferies and Centerview Partners […]

Altas Partners is poised to generate an about 3.5 x return on MyEyeDr through a sale of the optometry giant valued at US$2.7 billion, according to a source familiar with the matter. Goldman Sachs through West Street Capital Partners VII this week agreed to acquire the well-known brand by buying its management services company, Capital Vision Services. Toronto’s Altas partnered with Caisse de dépôt et placement du Québec in 2015 to acquire Capital Vision Services for US$775 million, the source said. The pending acquisition — the largest sponsor-backed transaction in vision care history — concludes a process that kicked off earlier this year.

As Goldman writes big check in eye care, others steer clear of retail health

Advarra formed via ’17 merger of Linden’s Chesapeake IRB, Northlane’s Schulman IRB EV-to-Ebitda multiple equates to ~18x IOIs submitted in late May Preempting the highly anticipated sales process for PE-backed Advarra, Genstar Capital agreed in June to buy the provider of compliance-related services for clinical research, according to sources familiar with the matter. The pending acquisition […]

Sell-side adviser: Evercore Spectrum Equity made growth equity investment in 2015 Boston-based Definitive Healthcare founded by CEO Jason Krantz Preempting the process for Spectrum Equity-backed Definitive Healthcare, Advent International is investing in the highly sought after healthcare-data provider, according to three sources. The transaction is valued around $1.7 billion, two sources said, while a third […]

Altas, CDPQ bought Vienna, VA, company for $775 mln in ’15 Sell-side adviser: Jefferies FFL’s EyeCare Partners to weigh options via Moelis Altas Partners is poised to generate an about 3.5x return on MyEyeDr through a sale of the optometry giant valued at $2.7 billion, according to a source familiar with the matter. Goldman Sachs through […]

Will the buzz around ‘Social Determinants of Health’ translate to PE investment?

Catholic health system bought Ensemble in May ’16 for up to $110 mln Sell-side financial adviser: Guggenheim First big healthcare-oriented tech deal for Golden Gate Golden Gate Capital agreed to acquire a slight majority stake in Ensemble Health Partners from Bon Secours Mercy Health, assigning the revenue-cycle-management division an enterprise value between $1.5 billion and $2 […]

Existing investors in GI: Waud, Frazier, Audax Sell-side adviser: Oppenheimer New MSO to be called U.S. Digestive Health Amulet Capital is marrying three southeast Pennsylvania gastroenterology groups in a transaction valued at $130 million, according to people familiar with the matter. The Greenwich, Connecticut, firm agreed to invest in and merge Regional Gi, Main Line Gastroenterology […]

Advarra formed via ’17 merger of Linden’s Chesapeake IRB and Northlane’s Schulman IRB Sell-side advisers: Jefferies, Houlihan Lokey Sources: Linden has express interest in reinvesting Advarra, the Linden Capital– and Northlane Capital-backed provider of compliance services that help streamline the drug-development process, is up for sale, according to sources familiar with the matter. First-round bids […]